Freedom of Information request on all suspected reactions reported in association with available COVID-19 vaccines ( FOI 22/353)
Published 31 May 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-31-january-2022/freedom-of-information-request-on-all-suspected-reactions-reported-in-association-with-available-covid-19-vaccines-foi-22353
FOI 22/353
3rd February 2022
Dear,
Thank you for your email. In response to your first query, the MHRA intends to publish all suspected reactions reported in association with available COVID-19 vaccines in an interactive format as interactive Drug Analysis Profiles (iDAPs), along with our ADR summary that is published each week. The use of iDAPs will enable users to view the data by categories of their choice such as age, sex and seriousness of reports. Users will also be able to download the data tables in CSV format.
As we plan to publish the data, we consider that your request is covered by Section 22 of the Freedom of Information Act (information intended for future publication) and the information you have asked for is therefore exempt from disclosure.
Section 22 is a qualified exemption which means we have considered whether there is a greater public interest in releasing the information requested or withholding it. We recognise there is strong interest in seeing this data and accept it should not be withheld however we wish to publish this information alongside appropriate context and assessment.
We will send you a link to the iDAPs once they are published.
Your second question relates to complete vaccination data which is not held by the MHRA. For this, we refer you to the Office for National Statistics who can be contacted here: Contact us - Office for National Statistics (ons.gov.uk).
I hope the information provided is helpful; however, if you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date of this response; and can be addressed to this email address.
Please remember to quote the reference number FOI 22/353 in any future communications.
Yours sincerely,
FOI Team,
Vigilance and Risk Management of Medicines Division